Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)

Harry L. Hébert; Abirami Veluchamy; Georgios Baskozos; Francesca Fardo; Dimitri Van Ryckeghem; Ewan R. Pearson; Lesley A. Colvin; Geert Crombez; David L.H. Bennett; Weihua Meng; Colin N.A. Palmer; Blair H. Smith

doi:10.1007/s00415-024-12721-6

Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)

Harry L. Hébert, Abirami Veluchamy, Georgios Baskozos, Francesca Fardo, Dimitri Van Ryckeghem, Ewan R. Pearson, Lesley A. Colvin, Geert Crombez, David L.H. Bennett, Weihua Meng, Colin N.A. Palmer, Blair H. Smith^*

^*Corresponding author af dette arbejde

Institut for Klinisk Medicin - Dansk Smerteforskningscenter

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Kommentar/debat/letter to the editor › Forskning › peer review

Abstract

In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).

Originalsprog	Engelsk
Bogserie	Journal of Neurology
Vol/bind	271
Nummer	12
Sider (fra-til)	7652-7653
Antal sider	2
ISSN	0340-5354
DOI	https://doi.org/10.1007/s00415-024-12721-6
Status	Udgivet - dec. 2024

Adgang til dokumentet

10.1007/s00415-024-12721-6Licens: CC BY

Andre filer og links

Link to publication in Scopus

Fingeraftryk

Dyk ned i forskningsemnerne om 'Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)'. Sammen danner de et unikt fingeraftryk.

1 Tidsskriftartikel

Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study
Hébert, H. L., Veluchamy, A., Baskozos, G., Fardo, F., Van Ryckeghem, D., Pearson, E. R., Colvin, L. A., Crombez, G., Bennett, D. L. H., Meng, W., Palmer, C. N. A. & Smith, B. H., feb. 2023, I: Journal of Neurology. 270, 2, s. 1076-1094 19 s.
Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review

Åben adgang
Fil
2 Citationer (Scopus)

3 Downloads (Pure)

Citationsformater

Hébert, H. L., Veluchamy, A., Baskozos, G., Fardo, F., Van Ryckeghem, D., Pearson, E. R., Colvin, L. A., Crombez, G., Bennett, D. L. H., Meng, W., Palmer, C. N. A., & Smith, B. H. (2024). Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0). Journal of Neurology, 271(12), 7652-7653. https://doi.org/10.1007/s00415-024-12721-6

@article{3984054e4d564e80a78d699c80aeb2c2,

title = "Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)",

abstract = "In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union{\textquoteright}s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union{\textquoteright}s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).",

author = "H{\'e}bert, {Harry L.} and Abirami Veluchamy and Georgios Baskozos and Francesca Fardo and {Van Ryckeghem}, Dimitri and Pearson, {Ewan R.} and Colvin, {Lesley A.} and Geert Crombez and Bennett, {David L.H.} and Weihua Meng and Palmer, {Colin N.A.} and Smith, {Blair H.}",

year = "2024",

month = dec,

doi = "10.1007/s00415-024-12721-6",

language = "English",

volume = "271",

pages = "7652--7653",

journal = "Journal of Neurology",

issn = "0340-5354",

publisher = "Springer",

number = "12",

}

Hébert, HL, Veluchamy, A, Baskozos, G, Fardo, F, Van Ryckeghem, D, Pearson, ER, Colvin, LA, Crombez, G, Bennett, DLH, Meng, W, Palmer, CNA & Smith, BH 2024, 'Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)', Journal of Neurology, bind 271, nr. 12, s. 7652-7653. https://doi.org/10.1007/s00415-024-12721-6

Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0). / Hébert, Harry L.; Veluchamy, Abirami; Baskozos, Georgios et al.
I: Journal of Neurology, Bind 271, Nr. 12, 12.2024, s. 7652-7653.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Kommentar/debat/letter to the editor › Forskning › peer review

TY - JOUR

T1 - Correction to

T2 - Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0)

AU - Hébert, Harry L.

AU - Veluchamy, Abirami

AU - Baskozos, Georgios

AU - Fardo, Francesca

AU - Van Ryckeghem, Dimitri

AU - Pearson, Ewan R.

AU - Colvin, Lesley A.

AU - Crombez, Geert

AU - Bennett, David L.H.

AU - Meng, Weihua

AU - Palmer, Colin N.A.

AU - Smith, Blair H.

PY - 2024/12

Y1 - 2024/12

N2 - In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).

AB - In the original version of this article, the funding information section was incorrectly given as This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). and should have read This work was supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633491 (DOLORisk). BHS, CNAP, DLHB, GC and WM are members of the DOLORisk consortium and are partly supported by this grant. HLH and AV are supported by DOLORisk. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. The Wellcome Trust United Kingdom Type 2 Diabetes Case–Control Collection (supporting GoDARTS) was funded by The Wellcome Trust (072960/Z/03/Z, 084726/Z/08/Z, 084727/Z/08/Z, 085475/Z/08/Z, and 085475/B/08/Z) and as part of the EU IMI-SUMMIT program. This research was also partly supported by the NIHR Oxford Health Biomedical Research Centre (NIHR203316), and by the Wellcome Trust (203139/Z/16/Z and 203139/A/16/Z). FF was supported by a European Research Council Starting Grant (ERC-2020-StG-948838).

UR - http://www.scopus.com/inward/record.url?scp=85208915957&partnerID=8YFLogxK

U2 - 10.1007/s00415-024-12721-6

DO - 10.1007/s00415-024-12721-6

M3 - Comment/debate/letter to the editor

C2 - 39535542

AN - SCOPUS:85208915957

SN - 0340-5354

VL - 271

SP - 7652

EP - 7653

JO - Journal of Neurology

JF - Journal of Neurology

IS - 12

ER -

Hébert HL, Veluchamy A, Baskozos G, Fardo F, Van Ryckeghem D, Pearson ER et al. Correction to: Development and external validation of multivariable risk models to predict incident and resolved neuropathic pain: a DOLORisk Dundee study (Journal of Neurology, (2023), 270, 2, (1076-1094), 10.1007/s00415-022-11478-0). Journal of Neurology. 2024 dec.;271(12):7652-7653. doi: 10.1007/s00415-024-12721-6